Separation Systems for Commercial Biotechnology

Report Code: BIO011E

Publish Date: Sep 2011

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.

Report Scope

Current and projected protein and biomolecule separation revenue forecasts during the forecast period (i.e., 2010 to 2016) are discussed.  Protein separation systems are playing important roles in new biopharmaceutical development.  Protein separation systems do not require U.S. Food and Drug Administration (FDA) approval, but the products produced from these processes do, and they must be produced in accordance with FDA good manufacturing practices (GMP) guidelines.  Thus, these separation procedures and equipment must pass FDA audits of the manufacturing process.  New products requiring separation technologies that have been approved by the FDA in 2009 and 2010 are covered, and those products expected to be approved within the forecast period are discussed.  Due to the timing of the writing of this report, the figures for 2011 are estimated except where actual results have been reported

The report includes analysis of the leading competitors, as well as emerging companies in the current global biomolecule separation market.  Profiles of the manufacturers of the leading products are analyzed, and their specific product strategies are outlined.  This report notes companies that are poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment.  This competitive environment is examined, with a special focus on the ways in which developing products and technologies are influencing the current standard of patient care.  Detailed profiles of the current market leaders and emerging companies are discussed in detail.

Market figures are based on revenues at the manufacturers’ level.  The base year for analysis and projection is 2010.  Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, and expanded indications for existing products. 

This report also includes overviews and forecasts of the separations market by product, by company, and by geographic region for the period from 2010 to 2016.  The global market is analyzed, and data are provided for each segment. 

Sales figures are reported in U.S. dollars and reflect currency fluctuations within the performance of revenue change.  Revenue figures do not account for variation in local currencies.

All market share data are presented on a global basis unless specifically noted. 

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007.  Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. 

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Separation Systems for Commercial Biotechnology129Free
Chapter- 1: INTRODUCTION5Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW41Free
Chapter- 4: CENTRIFUGATION SYSTEMS IN BIOTECHNOLOGY8Free
Chapter- 5: LIQUID CHROMATOGRAPHY IN BIOMOLECULAR SEPARATIONS IN BIOTECHNOLOGY11Free
Chapter- 6: ELECTROPHORESIS IN BIOMOLECULAR SEPARATIONS9Free
Chapter- 7: MEMBRANE FILTRATION IN BIOMOLECULAR SEPARATIONS9Free
Chapter- 8: NEW METHODS OF BIOMOLECULAR SEPARATION12Free
Chapter- 9: C. CRAMER & CO. GMBH21Free
Chapter- 10: PATENTS FOR BIOMOLECULAR SEPARATIONS-RELATED INSTRUMENTATION AND ACCESSORIES9Free
Chapter- 11: APPENDIX1Free
Published - Feb-2007| Analyst - Alpita Shah| Code - BIO011D

Report Highlights

  • The U.S. market for protein separation systems is estimated to be valued at almost $3.0 billion in the base year, 2006. This market is expected to grow with an average annual growth rate (AAGR) of 11.1% and cross the $5.0 billion by the year 2011.
  • The liquid chromatography market was $944 million in 2004 and will rise to more than $1.1 billion in the year 2006. This market has been showing exceptional growth due to its ability to separate large molecules before major analysis. This market is expected to reach $2.1 billion by 2011, an AAGR of 13.0%.
  • The membrane filtration segment is valued at $538 million in year 2006 with an estimated growth of 10.8% and is predicted to grow to $898 million in year 2011. Though the capital costs involved in membrane filtration are higher than chemical treatments, the system increases energy and utilizes less company space as compared to chemical processes. This enables companies to reduce costs by upwards of 65%.

Published - Nov-2003| Analyst - Norma Corbitt| Code - BIO011C

Report Highlights

  • Biotech separations is a $2.1 billion in the U.S. in 2003 and is projected to rise to $3.6 billion in 2008, at an average annual rate (AAGR) of 11.0%.
  • Fast runs, high throughput and reproducibility are factors in liquid chromatography’s dominance. Rising at an AAGR of 11.3%, this segment will increase to $1.69 billion in 2008.
  • Competition from membrane technologies should continue to limit growth of centrifugation to an AAGR of 6.0% through 2008
  • Readily met sanitary design regulations, easily enclosed systems and greater recovery rates contribute to an AAGR of 14.1% for membrane filtration. Sales should reach $673 million in 2008.
  • Electrophoresis systems, led by capillary designs, will rise at an AAGR of 8.3% from $249 million in 2003 to $371 million in 2008.

Related Reports

Next-Generation Cancer Diagnostics: Technologies and Global Markets

Published - Apr 2011 | Publisher - John Bergin | Code - BIO081A

The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a forecast market size of $5.3 billion in 2015.

Membrane Bioreactors: Global Markets

Published - Mar 2011 | Publisher - Susan Hanft | Code - MST047C

Valued at an estimated $337 million in 2010, the global MBR market is rising at a compound annual growth rate (CAGR) of 13.2% and is expected to reach $627 million by 2015. The MBR market is growing faster than both the larger market for wastewater treatment equipment and the market for other membrane systems treating wastewater.

Process Analytical Technologies for Pharmaceuticals: Global Markets

Published - Feb 2011 | Publisher - Varsha Bhat | Code - IAS034A

The global market for process analytical technology (PAT) instrumentation was valued at nearly $195 million in 2010. This market is expected to increase by a 7.4% compound annual growth rate (CAGR) to reach an estimated $279 million in 2015.

2010 Membrane and Separation Technology Research Review

Published - Jan 2011 | Publisher - Various Analysts | Code - MST053A

The 2010 Membrane and Separation Technology Research Review is designed to provide a glimpse into some of the market research reports we published this year. In the pages of this Review you will find excerpts from reports covering key membrane and separation technology markets.

Recent Reports

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - Partha Sarathi Das | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Viral Vector and Plasmid DNA: Technologies and Global Markets

Published - Apr 2024 | Publisher - Gundreddy Gopinadh | Code - BIO192B

The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

World Markets for Fermentation Ingredients

Published - Nov 2022 | Publisher - BCC Publishing | Code - FOD020G

The global fermentation-derived fine chemicals market should reach $42.4 billion by 2027 from $32.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.8% for the forecast period of 2022 to 2027.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Separation Systems for Commercial Biotechnology
Customize Report